WHAT WE DO

Banked organoids

Commercially Available PDOs

PDOs grown at scale using our proprietary bioprocess, commercially available off-the-shelf.

Bespoke development

Fee-for-Service Development and Manufacturing

Bespoke ‘Fee-for-Service’ development and scaled manufacturing of any (compatible) PDO lines.

Patient Derived Organoid

Enablement of PDO Technology

Full pipeline support for the enablement of PDO technology, from sourcing, line development, technology access, QMS and know-how.

NEWS

Innovate UK A4I project confirms relationship between organoid structure and drug treatment
Understanding organoid morphology: a study to assess organoid size and cell count from 3D image analysis
Validating Cellesce bioreactor technology for the expansion of patient-derived organoids

WHY CELLESCE?

Cellesce’s research and development continues at pace encompassing these main business drivers:
Scale-up and bioprocessing
Organoid lines
Morphometry
Immuno-oncology
Cellesce continues to build relationships within the organoid ecosystem to enable this patient centric technology and to drive forward PDO utilisation earlier in R&D.

OUR PARTNERS